Neueste Storys
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- mehr
Debiopharm Partners with Genedata to Digitalize Translational Research
Basel, Switzerland (ots) - Pioneer in advancing tomorrow’s standard of care to cure cancer and infectious diseases, Debiopharm selects Genedata Profiler, an industry-leading digital platform for translational and reverse translational research, as the cornerstone of its research and development strategy. Genedata, the leading provider of enterprise software solutions ...
mehr- 7
Camille Henrot – Sweet Days of Discipline |10 June – 5 November 2023, LOK
Ein Dokumentmehr Schweizerischer Nationalfonds / Fonds national suisse
1,500 new research projects and 400 fellowships abroad in anniversary year
Bern (ots) - In 2022, the SNSF approved 910 million francs for its regular funding schemes. We awarded a further 173 million for the Horizon Europe transitional measures. Coronavirus research generated a wealth of knowledge. On 1 August 2022, the SNSF celebrated its 70th anniversary. Founded in 1952 out of concern that Swiss research might sink into mediocrity after ...
mehrLaunched today: Infosys Topaz - An AI-first offering to accelerate business value for global enterprises using generative AI
Bengaluru, India (ots/PRNewswire) - - 12,000+ AI use cases, 150+ pre-trained AI models and 10+ AI platforms steered by AI-first specialists and data strategists - 'Responsible by design' approach ensures uncompromising ethics, trust, privacy, security and compliance Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a ...
mehrGrünenthal’s resiniferatoxin receives Breakthrough Therapy Designation from U.S. FDA for pain associated with osteoarthritis of the knee
Aachen (ots) - - Knee osteoarthritis is a progressive condition affecting over 360 million people worldwide and may have severe symptoms, including pain. - Grünenthal is running a global Phase III programme to investigate the efficacy and safety of intra-articular injections of resiniferatoxin, a non-opioid ...
mehr
Continental Integrates Imagry's Autonomous Driving Technology to Support Automated Parking for Mass Market Passenger Cars
Haifa, Israel (ots/PRNewswire) - - Solution automates parking spot exploration - Once a suitable parking spot has been identified by the system the vehicle will park autonomously, using Continental's and Imagry's technology - Function designed for use in both covered parking garages and uncovered parking lots - ...
mehrContinental Integrates Imagery's Autonomous Driving Technology to Support Automated Parking for Mass Market Passenger Cars
Haifa, Israel (ots/PRNewswire) - - Solution automates parking spot exploration - Once a suitable parking spot has been identified by the system the vehicle will park autonomously, using Continental's and Imagery's technology - Function designed for use in both covered parking garages and uncovered parking lots - ...
mehrEuropean study highlights need to improve the quality of conversations about induction of labour (IoL) in clinical settings
Amsterdam (ots/PRNewswire) - - Almost 1 in 2 women (49%) felt the experience of IoL differed from their expectations - The majority of expectant mothers (65%) did not feel fully involved in choosing which method of IoL they prefer - Findings emphasize the importance of collaborative decision-making between ...
mehrDEBIOPHARM LAUNCHES PHASE 1/2 COMBINATION TRIAL INVESTIGATING BRAIN-PENETRANT SELECTIVE WEE1 INHIBITOR FOR BRAIN CANCER PATIENTS
Lausanne (ots) - - Glioblastomas (GBM) are among the most aggressive and lethal tumors of the central nervous system with a 5-year survival rate of only 6.8%. - Debiopharm is combining its potent, brain penetrant WEE1 inhibitor Debio 0123 with standard of care (SOC) therapy. Debio 0123 hopes to hinder DNA damage ...
mehrAkkodis - Development partner for BMW i Vision Dee concept car
Zurich (ots/PRNewswire) - As an integral part of the development of the drivable concept car, Akkodis, a global leader in the Smart Industry, contributed its technical and digital expertise to the BMW i Vision Dee. Akkodis, part of the Adecco Group, has joined forces with the BMW Group to develop and produce the BMW i Vision Dee. Earlier this year, the BMW Group unveiled the BMW i Vision Dee to a global audience during ...
mehrMasdar, the Abu Dhabi Future Energy Company
Masdar and Airbus sign agreement to support development and growth of global sustainable aviation fuel market
Abu Dhabi, Uae (ots/PRNewswire) - - Use of sustainable aviation fuel estimated to reduce greenhouse gas emissions by up to 95 percent compared to existing jet fuel Abu Dhabi Future Energy Company PJSC – Masdar, one of the world's leading clean energy companies, has signed an agreement with Airbus, the largest ...
mehr
CSI Christian Solidarity International
Save Karabakh Coalition calls on Switzerland to act to protect besieged Armenians
mehrInfosys and bp Deepen their Relationship to Transform bp's Digital Application Landscape
Bengaluru, India (ots/PRNewswire) - - Modernize end-to-end application services to enhance operational efficiencies and business resilience - Build adaptive, agile and AI-amplified processes to accelerate innovation Infosys (NSE: INFY) (BSE:INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting and bp, a global integrated energy company, ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
Transition to a sustainable economy: policy recommendations
Bern (ots) - How can economic progress be aligned with social and environmental responsibility? In closing, the National Research Programme "Sustainable Economy" (NRP 73) presents recommendations in this regard. To mark its conclusion, the National Research Programme "Sustainable Economy: resource-efficient, future-oriented, innovative" (NRP 73) is presenting a white paper with recommendations to policymakers for the ...
mehrTechnology industry: subdued outlook for 2023
Zurich (ots) - The business situation in the Swiss technology industry (mechanical and electrical engineering industries and related technology sectors) is currently still good. Both sales (+4.9%) and exports (+2.8%) rose in the first quarter of 2023 compared with the previous year. However, the decline in new orders in the first quarter (-4.8%) and the low worldwide Purchasing Managers' Index (PMI) indicate considerably ...
mehr
China Matters' Feature: What Makes Ningbo-CEEC Connection Vibrant?
mehrEuro Airport Basel-Mulhouse-Freiburg
Ascension and Pentecost 2023: travel at ease thanks to a good preparation
Ein Dokumentmehr
- 4
Selecta FoodTech-Solutions
mehr FDI WORLD DENTAL FEDERATION'S VIRTUAL SUMMIT ON WORLD ENVIRONMENT DAY TO HIGHLIGHT SUSTAINABLE DENTAL PRACTICES FOR A GREENER FUTURE
mehr- 2
Haris Epaminonda, 8 July 2023 – 14 January 2024, Kunstmuseum St. Gallen
Ein Dokumentmehr Croma-Pharma receives marketing authorisation for Letybo® in a further 12 European markets
Vienna (ots/PRNewswire) - Croma (Croma-Pharma® GmbH) announced today that it has received marketing authorisation for Letybo®, the company's botulinum toxin product, in 12 additional European markets. These include Belgium, Cyprus, Czech Republic, Denmark, Finland, Greece, Hungary, Luxembourg, Malta, Norway, Slovakia and Sweden. Letybo® will be launched in these ...
mehr/C O R R E C T I O N -- Croma-Pharma/
Vienna (ots/PRNewswire) - In the news release, Croma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter, issued 09-May-2023 by Croma-Pharma over PR Newswire, we are advised by the company that the footnote [1] has been updated. The complete, corrected release follows: Croma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter - ...
mehrCroma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter
Vienna (ots/PRNewswire) - - Company reports strong financial results for 2022 with 27% revenue growth in 2022 and significantly increased margins - Growth driven by launch of Letybo® and its catalytic effect on the existing portfolio as well as strong market growth - Continued market share gains, strategic mid-term ...
mehr
Amicogen and Lysando: Novel approach for the treatment of mastitis in dairy cows
mehrSchweizerischer Nationalfonds / Fonds national suisse
The Covid-19 pandemic is preparing us for future crises
Bern (ots) - The SNSF Corona Research Conference shows how the Covid-19 pandemic has enabled us to accumulate knowledge that will be useful in dealing with future crises. "If we ever have to deal with a new pandemic in future we will not be starting from scratch, as was the case when we were confronted with the coronavirus." These are the words of scientist Barbara Rath. As an active participant in the Vienna Vaccine ...
mehrClose to USD 100m of new investment commitments by SIFEM in 2022
Bern (ots) - In 2022, the Swiss Investment Fund for Emerging Markets (SIFEM) committed a total of USD 95 million to seven new investments and concluded the year with a negative operating result of minus CHF 13.1 million. The seven new investments will contribute directly to the achievements of SIFEM's development goals, especially in terms of job creation, climate ...
mehrCredaris to acquire Crédits Conseils and expand its position as the leading Swiss credit broker
mehrCunard appoints Katie McAlister as president
Southampton, England (ots/PRNewswire) - Cunard has announced the appointment of Katie McAlister as president. Katie will join Southampton-based Cunard in August after a 20-year career with TUI where she is currently chief marketing officer, UK & Ireland. Carnival UK president Sture Myrmell said: "We are delighted to have someone of Katie's calibre join Cunard at this vital time of expansion. "Her commercial and ...
mehrSquaredFinancial Founder and CEO, Philippe Ghanem, takes over the business, Husam Al Kurdi moves on to pursue new venture
Seychelles, East Africa (ots/PRNewswire) - Moving on to his own venture but still collaborating together Moving on from his title as CEO of the CySEC-regulated entity of SquaredFinancial and Deputy CEO of SquaredFinancial Group, Husam Al Kurdi decides to focus on his own new venture while maintaining the role of ...
mehr